Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

42 Biggest Movers From Yesterday

Benzinga.com  November 17, 2017

40 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  November 16, 2017

40 Biggest Movers From Yesterday

Benzinga.com  November 16, 2017

Achillion Announces Pricing of Secondary Offering Of Common Stock

GlobeNewswire November 15, 2017

33 Stocks Moving In Wednesday's Mid-Day Session

Benzinga.com  November 15, 2017

A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Economic Reports

Benzinga.com  November 15, 2017

14 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com  November 14, 2017

Achillion Announces Proposed Secondary Offering of Common Stock

GlobeNewswire November 14, 2017

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

GlobeNewswire November 14, 2017

Achillion Announces ACH-4471 Granted Orphan Drug Designation by the FDA and Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

GlobeNewswire November 6, 2017

Achillion Reports Third Quarter 2017 Financial Results and Provides Update on Clinical Programs

GlobeNewswire November 1, 2017

32 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  October 27, 2017

USPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pathway Factor D Inhibitor

GlobeNewswire October 24, 2017

Achillion Announces Presentation of Data From OMEGA-1 Phase 2b Trial With Odalasvir, AL-335, and Simeprevir (JNJ-4178) at the 2017 Liver Meeting

GlobeNewswire October 23, 2017

Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and Agios Pharma

PR Newswire September 20, 2017

Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series

GlobeNewswire September 20, 2017

Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge

Benzinga.com  September 11, 2017

18 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  September 11, 2017

Achillion Announces Strengthening of Management Team

GlobeNewswire September 11, 2017

Achillion Announces Termination of Worldwide Collaboration for Hepatitis C With Janssen

GlobeNewswire September 11, 2017